FDA Approves Unknown Drug — BRISTOL MYERS SQUIBB
On December 28, 2012, the FDA granted approval to a new drug from Bristol-Myers Squibb, a move that may broaden the company's portfolio and influence competitive dynamics in the pharmaceutical market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed